Arvee Laboratories [ARVEE] vs Tanfac Industries [TANFACIND] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Arvee Laboratories (India) Ltd. wins in 9 metrics, Tanfac Industries Ltd. wins in 10 metrics, with 0 ties. Tanfac Industries Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Arvee Laboratories (India) Ltd. | Tanfac Industries Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 91.95 | 66.26 | Tanfac Industries Ltd. |
| Price-to-Book Ratio | 6.13 | 14.61 | Arvee Laboratories (India) Ltd. |
| Debt-to-Equity Ratio | 3.29 | 9.28 | Arvee Laboratories (India) Ltd. |
| PEG Ratio | 0.08 | -0.85 | Arvee Laboratories (India) Ltd. |
| EV/EBITDA | 89.75 | 41.73 | Tanfac Industries Ltd. |
| Profit Margin (TTM) | 7.64% | 10.85% | Tanfac Industries Ltd. |
| Operating Margin (TTM) | 13.51% | 12.17% | Arvee Laboratories (India) Ltd. |
| EBITDA Margin (TTM) | 13.51% | 12.17% | Arvee Laboratories (India) Ltd. |
| Return on Equity | 6.87% | 28.25% | Tanfac Industries Ltd. |
| Return on Assets (TTM) | 5.71% | 20.67% | Tanfac Industries Ltd. |
| Free Cash Flow (TTM) | $-20.60M | $-641.87M | Arvee Laboratories (India) Ltd. |
| Dividend Yield | N/A | 0.34% | N/A |
| 1-Year Return | 3.22% | 21.76% | Tanfac Industries Ltd. |
| Price-to-Sales Ratio (TTM) | 6.98 | 7.19 | Arvee Laboratories (India) Ltd. |
| Enterprise Value | $1.83B | $49.64B | Tanfac Industries Ltd. |
| EV/Revenue Ratio | 6.75 | 7.20 | Arvee Laboratories (India) Ltd. |
| Gross Profit Margin (TTM) | 50.88% | 36.49% | Arvee Laboratories (India) Ltd. |
| Revenue per Share (TTM) | $25 | $346 | Tanfac Industries Ltd. |
| Earnings per Share (Diluted) | $1.87 | $37.53 | Tanfac Industries Ltd. |
| Beta (Stock Volatility) | 0.58 | -0.21 | Tanfac Industries Ltd. |
Arvee Laboratories (India) Ltd. vs Tanfac Industries Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Arvee Laboratories (India) Ltd. | -0.80% | 5.92% | 3.55% | 9.37% | -14.78% | -17.06% |
| Tanfac Industries Ltd. | 2.42% | 4.75% | -5.30% | 21.67% | 3.33% | -4.06% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Arvee Laboratories (India) Ltd. | 3.22% | 51.92% | 45.32% | 460.53% | 460.53% | 460.53% |
| Tanfac Industries Ltd. | 21.76% | 106.11% | 1,505.29% | 11,875.37% | 13,352.33% | 13,912.85% |
Performance & Financial Health Analysis: Arvee Laboratories (India) Ltd. vs Tanfac Industries Ltd.
| Metric | ARVEE | TANFACIND |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.82B | ₹49.61B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 4,114 | 22,308 |
| 90 Day Avg. Volume | 1,980 | 16,696 |
| Last Close | ₹169.31 | ₹2,066.65 |
| 52 Week Range | ₹129.11 - ₹290.78 | ₹1,625.00 - ₹2,585.00 |
| % from 52W High | -41.77% | -20.05% |
| All-Time High | ₹315.00 (Apr 08, 2024) | ₹5,064.30 (Aug 29, 2025) |
| % from All-Time High | -46.25% | -59.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | -0.03% |
| Quarterly Earnings Growth | 10.80% | -0.55% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.11% |
| Operating Margin (TTM) | 0.14% | 0.12% |
| Return on Equity (TTM) | 0.07% | 0.28% |
| Debt to Equity (MRQ) | 3.29 | 9.28 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹28.06 | ₹170.18 |
| Cash per Share (MRQ) | ₹6.26 | ₹14.38 |
| Operating Cash Flow (TTM) | ₹26.83M | ₹523.26M |
| Levered Free Cash Flow (TTM) | ₹21.47M | ₹881.47M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.34% |
| Last 12-Month Dividend | N/A | ₹16.00 |
Valuation & Enterprise Metrics Analysis: Arvee Laboratories (India) Ltd. vs Tanfac Industries Ltd.
| Metric | ARVEE (Apr 24, 2026) | TANFACIND (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 91.95 | 66.26 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 0.08 | -0.85 |
| Price to Sales (TTM) | 6.98 | 7.19 |
| Price to Book (MRQ) | 6.13 | 14.61 |
| Market Capitalization | ||
| Market Capitalization | ₹1.82B | ₹49.61B |
| Enterprise Value | ₹1.83B | ₹49.64B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.75 | 7.20 |
| Enterprise to EBITDA | 89.75 | 41.73 |
| Risk & Other Metrics | ||
| Beta | 0.58 | -0.21 |
| Book Value per Share (MRQ) | ₹28.06 | ₹170.18 |
Financial Statements Comparison: Arvee Laboratories (India) Ltd. vs Tanfac Industries Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ARVEE (2025) | TANFACIND (2025) |
|---|---|---|
| Revenue/Sales | 384.38M | 5.51B |
| Cost of Goods Sold | 249.29M | 3.18B |
| COGS % of Revenue | 64.9% | 57.8% |
| Gross Profit | 135.09M | 2.32B |
| Gross Margin | 35.1% | 42.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 24.63M | 1.21B |
| Operating Margin | 6.4% | 22.0% |
| EBITDA | 40.39M | 1.29B |
| EBITDA Margin | 10.5% | 23.4% |
| Pre-Tax Income | 28.71M | 1.19B |
| Pre-Tax Income % of Revenue | 7.5% | 21.6% |
| Income Tax | 7.24M | 306.14M |
| Income Tax % of Revenue | 1.9% | 5.6% |
| Net Income (Profit) | 21.47M | 881.47M |
| Profit Margin | 5.6% | 16.0% |
Balance Sheet & Liquidity Metrics
| Metric | ARVEE (2025) | TANFACIND (2025) |
|---|---|---|
| Cash & Equivalents | 2.11M | 301.18M |
| Total Current Assets | 196.64M | 2.46B |
| Total Current Assets % of Revenue | 51.2% | 44.8% |
| Total Current Liabilities | 38.27M | 1.08B |
| Total Current Liabilities % of Revenue | 10.0% | 19.6% |
| Long-Term Debt | 10.33M | N/A |
| Long-Term Debt % of Revenue | 2.7% | 0.0% |
| Total Shareholders Equity | 312.61M | 3.12B |
| Retained Earnings | 183.05M | 2.62B |
| Retained Earnings % of Revenue | 47.6% | 47.6% |
| Property, Plant & Equipment | 14.73M | 1.68B |
Cash Flow Statement Comparison
| Metric | ARVEE (2025) | TANFACIND (2025) |
|---|---|---|
| Operating Cash Flow | 26.83M | 523.26M |
| Operating Cash Flow % of Revenue | 7.0% | 9.5% |
| Capital Expenditures | -18.52M | -968.83M |
| Free Cash Flow | -20.60M | -641.87M |
| FCF Margin | -5.4% | -11.7% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ARVEE | TANFACIND |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 11.02M | 19.95M |
| Float Shares | 6.96M | 7.01M |
| % Held by Insiders | N/A | 70.86% |
| % Held by Institutions | N/A | 0.03% |
| % Held by Public | N/A | 29.11% |
Dividend Analysis & Yield Comparison: Arvee Laboratories (India) Ltd. vs Tanfac Industries Ltd.
| Metric | ARVEE | TANFACIND |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹16.00 |
| Last 12-Month Dividend Yield | N/A | 0.34% |
| 3-Year Avg Annual Dividend | N/A | ₹7.50 |
| 3-Year Avg Dividend Yield | N/A | 0.30% |
| 3-Year Total Dividends | N/A | ₹22.50 |
| Ex-Dividend Date | N/A | Sep 17, 2025 |